CYT-004-MelQbG10

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCYT-004-MelQbG10
Drug Alias NameMelanoma virus-like particle vaccineMelan-A VLP vaccineCYT-004-MelQbG10
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionT lymphocytes stimulants
TargetsMelanoma antigen recognized by T-cells 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKuros Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytos Biotechnology Ag
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A